Watershed Asset Management, L.L.C. Ironwood Pharmaceuticals Inc Transaction History

Watershed Asset Management, L.L.C.

  • $85.3 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
BUY
$10.1 - $11.6 $233,390 - $268,052
23,108 New
23,108 $245,000
Q4 2022

Feb 03, 2023
BUY
$9.9 - $12.43 $231,323 - $290,439
23,366 New
23,366 $289,000
Q1 2022

May 13, 2022
SELL
$10.61 - $12.88 $249,706 - $303,130
-23,535 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$10.86 - $13.95 $255,590 - $328,313
23,535 New
23,535 $274,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Watershed Asset Management, L.L.C. Portfolio

Follow Watershed Asset Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email